Drug Shortage Report for ALVESCO
Report ID | 59166 |
Drug Identification Number | 02285614 |
Brand name | ALVESCO |
Common or Proper name | ciclesonide |
Company Name | COVIS PHARMA GMBH |
Market Status | MARKETED |
Active Ingredient(s) | CICLESONIDE |
Strength(s) | 200MCG |
Dosage form(s) | AEROSOL, METERED DOSE |
Route of administration | INHALATION |
Packaging size | 30 doses |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2018-09-01 |
Actual start date | 2018-09-01 |
Estimated end date | 2018-11-01 |
Actual end date | 2018-10-22 |
Shortage status | Resolved |
Updated date | 2018-10-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | GRAFENAUWEG 12 ZUG, ZUG SWITZERLAND 6300 |
Company contact information | Covis Pharma GmbH Grafenauweg 12 Zug, 6300 Switzerland |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2018-10-23 | English | Compare |
v10 | 2018-10-22 | French | Compare |
v9 | 2018-10-22 | English | Compare |
v8 | 2018-09-21 | French | Compare |
v7 | 2018-09-21 | English | Compare |
v6 | 2018-09-04 | French | Compare |
v5 | 2018-09-04 | English | Compare |
v4 | 2018-09-02 | English | Compare |
v3 | 2018-08-25 | French | Compare |
v2 | 2018-08-25 | English | Compare |
v1 | 2018-08-25 | English | Compare |
Showing 1 to 11 of 11